[RETIREMENT] Sylvie Chalon, good bye & thank you !

Sylvie Chalon

Her research work was based on the hypothesis that exploration of specific brain targets (receptors, transporters, abnormal proteins) by molecular SPECT/PET imaging allow to improve the knowledge, diagnosis and treatment of neurodevelopmental and neurodegenerative disorders. Her activity was focussed on animal models of these disorders, with an innovative technological aspect (validation and use of radiopharmaceuticals) and a more fundamental aspect based on the role of neurotransmission systems in brain dysfunction. Her main research projects, granted by regional, national (Fondation Alzheimer, ANR) and international (H2020) programs involved in vivo exploration of dopaminergic, cholinergic and  neuroinflammatory markers in animal models (Parkinson, Alzheimer, prenatal exposure to drugs), using a microPET/CT system and 18F-labeled tracers developed in the team.